von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M [8]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 9, 2006, Pages 2088-2090

  Baronciani, Luciano ^a,b   Federici, A B ^a,b   Cozzi, G ^a,b   Canciani, M T ^a,b   Mannucci, P M ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; RISTOCETIN; VON WILLEBRAND FACTOR;

BINDING ASSAY; BLEEDING TIME; BLOOD CLOTTING DISORDER; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE LOCUS; GENE MUTATION; HEMOSTASIS; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; SCREENING TEST; THROMBOCYTE AGGLUTINATION; THROMBOCYTE FUNCTION AND CHARACTERISTICS; VON WILLEBRAND DISEASE;

COLLAGEN; HUMANS; MUTATION, MISSENSE; PROTEIN BINDING; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 33747161013     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02069.x     Document Type: Letter

References (10)

1. Baronciani L, Federici AB, Beretta M, Cozzi G, Canciani MT, Mannucci PM. Expression studies on a novel type 2B variant of the von Willebrand factor gene (R1308L) Characterized by defective collagen binding. J Thromb Haemost 2005; 3: 2689-94.
2. Favaloro EJ. 2B or not 2B? What is the role of VWF in platelet-matrix interactions? And what is the role of the VWF:CB in VWD diagnostics? These are the questions. J Thromb Haemost 2006; 4: 892-3.
3. Federici AB, Castaman G, Mannucci PM. Italian Association of Hemophilia Guidelines for the diagnosis and management of von Willebrand disease in Italy. Haemophilia 2002; 8: 607-21.
4. Castaman G, Federici AB, Rodeghiero F, Mannucci PM. Willebrand's disease in the year 2003: Towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003; 88: 94-108.
5. Macfarlane DE, Stibbe J, Kirby E, Zucker MB, Grant RA, McPherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306-18.
6. Federici AB, Canciani MT, Forza I, Mannucci PM, Marchese P, Ware J, Ruggeri ZM. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for diagnosis of patients with low von Willebrand factor levels. Haematologica 2004; 89: 77-85.
7. Ribba A-S, Loisel I, Lavergne J-M, Juhan-Vague L, Obert B, Cherel G, Meyer D, Girma J-P. Ser968Thr Mutation within A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen. Thromb Haemost 2001; 86: 848-54.
8. Mazzuccato M, Spessotto P, Masotti A, De Apollonia L, Cozzi MR, Yosshioka A, Perris R, Colombatti A, De Marco L. Identification of domains responsible for von Willebrand Factor Type VI collagen interaction mediating platelet adhesion under high flow. J Biol Chem 1999; 274: 3033-41.
9. Federici AB, Canciani MT, Forza I, Cozzi G. Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease: Single center comparison of four different assays. Thromb Haemost 2000; 84: 1127-8.
10. Favaloro EJ. Collagen binding assay for von Willebrand factor (VWF:CB): detection of von Willebrand disease (VWD) and discrimination of VWD subtypes, depends on collagen sources. Thromb Haemost 2000; 83: 127-35.